As of September 30, 2026, Heren Health Co., Ltd. Class A carries a market capitalization of 3.63B, placing it among publicly traded companies globally. Its enterprise value stands at 3.24B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.63B |
| Enterprise Value | 3.24B |
As of September 30, 2026, Heren Health Co., Ltd. Class A has 262.56M shares outstanding.
| Shares Outstanding | 262.56M |
These figures are as of September 30, 2026. The price-to-sales ratio is 9.36, and the price-to-book ratio stands at 3.36.
| PS Ratio | 9.36 |
| PB Ratio | 3.36 |
| P/TBV Ratio | 3.68 |
These figures are as of September 30, 2026. The EV/Sales ratio of 8.33 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 3.24B versus a market cap of 3.63B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 8.33 |
As of September 30, 2026, Heren Health Co., Ltd. Class A maintains a current ratio of 3.94, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.27, indicating conservative leverage, while an interest coverage ratio of -18.77 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.94 |
| Quick Ratio | 1.55 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | -0.11 |
| Interest Coverage | -18.77 |
Over the twelve months ended September 30, 2026, Heren Health Co., Ltd. Class A posted a negative return on equity (ROE) of -2.57, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.99, reflecting losses generated across the asset base. The company generates approximately 488,968.06 in revenue per employee across its workforce of 794.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 6.34 indicates how many times Heren Health Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -2.57 |
| Return on Assets (ROA) | -1.99 |
| Revenue Per Employee | 488,968.06 |
| Employee Count | 794.00 |
| Inventory Turnover | 6.34 |
Over the twelve months ended September 30, 2026, Heren Health Co., Ltd. Class A recorded an income tax benefit of -3.52M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -29.27M and -28.06M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -3.52M |
As of the close on November 17, 2026, Heren Health Co., Ltd. Class A's stock has declined approximately 2.72% over the past 52 weeks. The 50-day moving average sits at 13.48, while the 200-day moving average is 13.23.
| 52-Week Price Change | -2.72% |
| 50-Day Moving Average | 13.48 |
| 200-Day Moving Average | 13.23 |
Over the twelve months ended September 30, 2026, Heren Health Co., Ltd. Class A generated 388.24M in revenue and converted that into -28.06M in net income, yielding earnings per share of -0.10. EBITDA reached -27.06M, while operating income came in at -4.04M.
| Revenue | 388.24M |
| Gross Profit | 126.82M |
| Operating Income | -4.04M |
| Pretax Income | -29.27M |
| Net Income | -28.06M |
| EBITDA | -27.06M |
| EBIT | -27.06M |
| Earnings Per Share (EPS) | -0.10 |
As of September 30, 2026, Heren Health Co., Ltd. Class A holds 428.52M in cash and equivalents against 3.03M in total debt, resulting in a net debt position of -342.98M. Total book value stands at 1.08B, with working capital of 810.00M providing operational flexibility.
| Cash & Cash Equivalents | 428.52M |
| Total Debt | 3.03M |
| Net Debt | -342.98M |
| Equity (Book Value) | 1.08B |
| Book Value Per Share | 4.12 |
| Working Capital | 810.00M |
These figures cover the twelve months ended September 30, 2026.
| Capital Expenditures | -40.86M |
Over the twelve months ended September 30, 2026, Heren Health Co., Ltd. Class A posted a gross margin of 32.67, reflecting its pricing power and cost economics. The operating margin of -1.04 and net profit margin of -7.23 provide insight into operational efficiency.
| Gross Margin | 32.67 |
| Operating Margin | -1.04 |
| Pretax Margin | -7.54 |
| Profit Margin | -7.23 |
| EBITDA Margin | -6.97 |
Over the twelve months ended September 30, 2026, Heren Health Co., Ltd. Class A paid dividends of 0.04 per share. The dividend payout ratio of -39.69 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 1.73, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Heren Health Co., Ltd. Class A shareholders.
| Dividend Per Share | 0.04 |
| Payout Ratio | -39.69 |
| Shareholder Yield | 1.73 |
Heren Health Co., Ltd. Class A's most recent stock split took place on June 16, 2021 with a 5:7 split ratio.
| Last Split Date | 6/16/2021 |
| Split Ratio | 5:7 |
As of September 30, 2026, Heren Health Co., Ltd. Class A has an Altman Z-Score of 9.06, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 9.06 |
Already premium?